A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies

Journal of Clinical Pathology

Volumn 51, Issue 8, 1998, Pages 568-575

  Savige, J A ^a,k   Paspaliaris, B ^b   Silvestrini, R ^c   Davies, D ^d   Nikoloutsopoulos, T ^e   Sturgess, A ^f   Neil, J ^g   Pollock, W ^h   Dunster, K ⁱ   Hendle, M ^j  

^a AUSTIN HEALTH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^e FLINDERS MEDICAL CENTRE   (Australia)

^f ST GEORGE HOSPITAL   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^h Immunology Laboratory   (Australia)

ⁱ ALFRED HOSPITAL   (Australia)

^j Queensland Medical Laboratories   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Antigens; Antineutrophil cytoplasmic antibodies; Autoantibodies; Vasculitis

Indexed keywords

AUTOANTIBODY; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY SPECIFICITY; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; TISSUE SPECIFICITY; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 7344249543     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.8.568     Document Type: Review

References (38)

1. Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. N Engl J Med 1988;316:1651-7.
2. Van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-9.
3. Niles JL, McCluskey RT, Ahmad MF, et al. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989;74:1888-93.
4. Goeken JA. Antineutrophil cytoplasmic antibody - a useful serological marker for vasculitis. J Clin Immunol 1991;11: 161-74.
5. Snook JA, Chapman RW, Fleming K, et al. Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989;76: 30-1
6. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
7. Scott DGI, Sharrack BR, Webb FWS. Antineutrophil cytoplasmic antibodies and rheumatoid arthritis [abstr]. Clin Exp Rheumatol 1990;8(suppl 4):F24.
8. Zhao M-H, Lockwood CM. ANCA defines the clinical disease manifestations of vasculitis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 1996;13:221-6.
9. Lock RJ. Detection of autoantibodies to neutrophil cytopasmic antigens. J Clin Pathol 1994;47:4-8.
10. Coremans IEM, Hagen EC, Daha MR, et al. Antilactoferrin antibodies in patients with arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466-75.
11. Nassberger L, Jonsson H, Sjoholm AG, et al. Circulating antielastase in systemic erythematosus. Lancet 1989;i:509.
12. Flesch BK, Lampe M, Rautman A, et al. Antielastase, cathepsin G and lactoferrin antibodies in sera with cANCA or with atypical fluorescence staining pattern [abstr]. Am J Kidney Dis 1991;18:201A.
13. Zhao MH, Jones SJ, Lockwood CM. Bactericidal/ permeability increasing (BPI) protein is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995;99:49-56.
14. Wiik A, Kjeldsen L, Borregaard N, et al. The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens. Clin Exp Immunol 1995;101:15-17.
15. Faber V, Elling P. Leucocyte-specific antinuclear factors in patients with Felty's syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases. Acta Med Scand 1967;179:257.
16. Wiik A. Granulocyte-specific antinuclear antibodies. Allergy 1980;35:263-89.
17. Nielson H, Wiik A, Elmgreen J. Granulocyte specific antinuclear antibodies in ulcerative colitis. Acta Pathol Microbiol Immunol Scand 1983;91 (section C):23-6.
18. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA [abstr]. APMIS 1989;97(suppl 6):12-13.
19. Cohen Tervaert JW, Stegeman CA, Kallenberg CGM. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 1996;13:241-5.
20. De'Oliveria J, Gaskin G, Dash A, et al. Relationship between disease activity and antineutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 1995;25:380-9.
21. Segelmark M, Baslund B, Wieslander J. Some patients with antimyeloperoxidase antibodies have a cANCA pattern. Clin Exp Immunol 1994;96:458-65.
22. Yang JJ, Turtle R, Falk RJ, et al. Frequency of antibactericidal/permeability increasing protein (BPI) and anti-azurocidin in patients with renal disease. Clin Exp Immunol 1996;105:125-31.
23. Sediva A, Bartunkova J, Kolarova I, et al. ANCA with specificity for bactericidal permeability-increasing protein in children with cystic fibrosis [abstr]. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 1996;13:275 A.
24. Mallon D, Silvestrini R, Benson E. Clinical findings in patients with positive cytoplasmic immunofluorescence with negative ELISA for proteinase 3. Nephrology 1997;3: S792A.
25. Charles LA, Falk RJ, Jennette JC. Reactivity of antineutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol 1989;53:243-53.
26. Teeraratkul P, Thorson JA, Kemp JD, et al. Identification of apparent dual ANCA specificities in a subset of patients with systemic vasculitis and crescentic glomerulonephritis. In: Gross WL, ed. ANCA-associated vasculitides: immunological and clinical aspects. New York: Plenum Press, 1993.
27. Dolman KM, Gans ROB, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993;342:651-2.
28. Nassberger L, Sjoholm AG, Jonsson H, et al. Autoantibodies against neutrophil cytoplasmic components in systemic lupus erythematosus and in hydralazine induced lupus. Clin Exp Immunol 1990;81:380-3.
29. Niles JL, Pan G, Collins AB, et al. Value of antigen-specific radioimmunoassays for measuring antineutrophil cytoplasmic antibodies (ANCA) in the differential diagnosis of rapidly progressive glomerulonephritis. J Am Soc Nephrol 1991;2:27-36.
30. La Cour BB, Wiik A, Hoier-Madsen M, et al. Clinical correlates and substrate specificities of antibodies exhibiting neutrophil nuclear reactivity. A methodological study. J Immunol Methods 1995;187:287-95.
31. Christenson VD, Dooley MA, Allen NB. Discrimination of antineutrophil antibodies from antinuclear antibodies using immunofluorescence on neutrophils and HL60 cells. J Rheumatol 1991;18:575-9.
32. Lee SS, Lawton JWM, Chak W. Distinction between antinuclear antibody and pANCA. J Clin Pathol 1991;44: 962-3.
33. Spickett GP, Broomhead V. Formalin fixation and patterns of antineutrophil cytoplasmic antibodies. J Clin Pathol 1995;48:89-90.
34. Orth T, Gerken G, Schwarting A, et al. ANCA in type I autoimmune hepatitis are mainly directed against actin [abstr]. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 1996;13:278A.
35. Verheught FWA, van Nord-Bokkorst JC, von dem Borne AEGK, et al. A family with alloimmune neonatal neutropenia: group-specific pathogenicity of maternal antibodies. Vox Sang 1979;36:1-8.
36. Stroncek DF, Egging MS, Eiber GA, et al. Neutrophil alloantibodies react with cytoplasmic antigens as possible cause of false-positive indirect immunofluorescence assays for antibodies to neutrophil cytoplasmic antigens. Am J Kidney Dis 1993;21:368-73.
37. Koderisch J, Andrassy K, Rasmussen N, et al. "False-positive" antineutrophil cytoplasmic antibodies in HIV infection [letter]. Lancet 1990;335:1227-8.
38. Davenport A. "False-positive" perinuclear and cytoplasmic antineutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and or microscopic polyarteritis. Clin Nephrol 1992;37:124-30.